🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Status
Active Not Recruiting
Location
UAB Comprehensive Cancer Center
Start Date
1999-03-25
Trial ID
NCT00003641
Treatments Being Tested
The goal of this clinical study is to learn if Pegasys (pegylated interfero...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT00962715
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Status
Terminated
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2007-10
Trial ID
NCT00470093
Treatments Being Tested
RATIONALE: Biological therapies, such as interleukin-2 and interferon, may ...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00416871
Treatments Being Tested
The purpose of the study is to determine whether interferon-alpha is effect...
Status
Unknown
Location
The Mengchao hepatobiliary hospital，Fujian Medical University，and Liver disease research center of Fujian province
Start Date
2012-08
Trial ID
NCT01681446
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cisplatin and gemcitabine, w...
Status
Unknown
Location
University of Texas Health Science Center at Houston
Start Date
2002-07
Trial ID
NCT00082862
Treatments Being Tested
The goal of this clinical trial is to learn if adding alpha interferon to s...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT07671495
The purpose of this study is to determine the safety, tolerability and dose...
Status
Completed
Location
Ohio State University
Start Date
2006-01
Trial ID
NCT01462773
Treatments Being Tested
RATIONALE: Comparing results of MRI scans done after bevacizumab may help d...
Status
Unknown
Location
Addenbrooke's Hospital
Start Date
2008-04
Trial ID
NCT00873236
Treatments Being Tested
RATIONALE: Imatinib mesylate and interferon alfa may interfere with the gro...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2001-04
Trial ID
NCT00015847
Treatments Being Tested